Search for: "Novartis Inc., c/o Novartis Corp"
Results 21 - 40
of 50
Sorted by Relevance
|
Sort by Date
23 Jun 2014, 12:57 pm
Sox, Michael C. [read post]
27 Jul 2009, 7:18 am
Wal-Mart Stores Inc, et al (Peter Zura's 271 Patent Blog) District Court N D Illinois: Inventor/plaintiff’s Managing Director not given highly confidential technical information: McDavid Knee Guard Inc v Nike USA Inc (Chicago Intellectual Property Law Blog) District Court E D Pennsylvania: Warsaw Orthpedic awarded $2M in Globus patent dispute (Patent Docs) District Court E D Texas: ‘I have good cause but it’s a secret’… [read post]
27 Aug 2011, 7:55 pm
P. 56(c). [read post]
15 Feb 2008, 9:00 am
You can separately subscribe to the IP Thinktank Global week in Review at [duncanbucknell.com]Highlights this week included:EU wants 95 year copyright on recordings: (IPKat), (Ars Technica), (Intellectual Property Watch), (IP Law360),Harvard Arts and Sciences Faculty decides to allow open access to research: (Techdirt), (Michael Geist), (Ars Technica), (Against Monopoly),Summary judgment hearing 8 Feb: Tafas & GSK v Dudas concerning implementation of the USPTO’s new examination… [read post]
27 Feb 2009, 7:00 am
(Inventive Step) (Patent Docs) US Patents Applying Supreme Court precedent: Carlsbad Technology v HIF Bio (Patently-O) (Hal Wegner) USPTO not laying off employees (IP Watchdog) USPTO maintenance fees (Patently-O) Merchants warranty of non-infringement (Patently-O) PLI patent bar review tour (IP Watchdog) Provisional patent applications: waiting to file non-provisionals (Patently-O) 35 USC § 315(C) and its uncodified cousin –… [read post]
22 May 2014, 5:00 am
” Id. at §20.1(c). [read post]
25 Jun 2009, 4:29 am
Novartis Pharmaceuticals Corp., 541 F. [read post]
5 Sep 2008, 11:01 pm
: (Chinese Law Prof Blog), China – The intellectual property rights crisis: (Ezine @rticles) Europe European Court of Justice to consider trade mark questions in Case C-342/08 Makro Zelfbedieningsgroothandel e.a. [read post]
9 Apr 2015, 5:00 am
Novartis Pharmaceuticals Corp., 2011 WL 1533467, at *9-10 (E.D.N.Y. [read post]
25 Jan 2008, 1:00 am
: (IP ThinkTank),IBM patents and defensive publishing: (Securing Innovation),Stockholm Network paper on developing nations and pharmaceutical patents: (IPcentral Weblog),Good and bad news for the IP industry if recession does bite: (IAM),Business Software Alliance: Piracy economic impact is tens of billions of dollars: (Ars Technica),IP portfolio costs - when less is more: (IP ThinkTank),IP protection: Competitive market default: (The Fire… [read post]
8 Feb 2008, 7:00 pm
– Facebook’s contractual rights to users’ photos problematic: (Spicy IP)PharmaEuropean Commission probes pharmaceutical sector: (Philip Brooks),WHO Board sets course on IP, avian flu, tighter publication policy: (Intellectual Property Watch),India: The Competition Act, patents and over hyped drugs: (Part I - Spicy IP), (Part II – Spicy IP), (Part III – Spicy IP),Ignoring not the solution –… [read post]
25 Jul 2008, 7:04 am
Here is IP Think Tank’s weekly selection of top intellectual property news breaking in the blogosphere and internet. [read post]
9 Aug 2008, 1:50 am
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: The end of William Patry’s blog: (Patry Copyright Blog), (Excess Copyright), (Patently-O), (Chicago IP Litigation Blog), (Michael Geist), (The Fire of Genius), (Techdirt), (Patry Copyright Blog), Kitchin J clarifies scope of biotech patents, in particular gene sequence patents: Eli Lilly & Co v Human Genome Sciences:… [read post]
12 Dec 2021, 2:22 pm
Novartis Pharms. [read post]
22 Feb 2008, 6:00 pm
Signature Financial Group, Inc., and AT&T Corp. v. [read post]
7 Jun 2007, 10:52 am
Pfizer, Inc., 198 F. [read post]
4 Apr 2008, 1:00 am
, (Ars Technica), (Patent Prospector), (Washington State Patent Law Blog), (IP Law Observer), (PLI), (PLI), (IP Updates), (Patent Docs), (Peter Zura’s 271 Patent Blog), (The Invent Blog), (IP Spotlight), (Just a Patent Examiner), (Techdirt), (Patent Baristas), (IPBiz), (IPBiz), (Patently-O), (IAM), (IP ThinkTank), (Against Monopoly), (Against Monopoly), (IP Law360), (Hal Wegner), (Ladas & Parry), Global Global - General Virtual monopoly – four strategic… [read post]
26 May 2015, 7:42 am
The ideal defendant’s case might occur in several ways: similar biomarker evidence would point a finger at a purely genetic cause or at some other (perhaps voluntary or non-anthropogenic) exposure; or, a person exposed to a toxin known to cause the person's disease in susceptible people might have a gene that completely neutralized the toxic effect and also might lack a biomarker that is uniformly found in people whose disease was caused by exposure.Steve C. [read post]
18 Jul 2008, 8:34 am
: (Patent Circle), Tanzania to conduct study on impact of counterfeit medicines: (Afro-IP), US: New rules on generic biological medicines under US Congressional debate: (Intellectual Property Watch), Pharma & Biotech - Products Acular (Ketorolac) – US: CAFC rules against Apotex reverse doctrine of equivalents: Roche Palo Alto & Allergan, Inc v Apotex: (Patent Circle), Carbatrol (Carbamazapine) – US: Federal judge allows Corepharma to seek DJ that its… [read post]
19 Mar 2022, 2:09 pm
Risk assessments would seemingly be about assessing risks, but they are not. [read post]
